| Boron Difluoride Curcuminoid Fluorophores with Enhanced Two‐Photon Excited Fluorescence Emission and Versatile Living‐Cell Imaging Properties K Kamada, T Namikawa, S Senatore, C Matthews, PF Lenne, O Maury, ... Chemistry–A European Journal 22 (15), 5219-5232, 2016 | 90 | 2016 |
| Chelation and stabilization of berkelium in oxidation state +IV GJP Deblonde, M Sturzbecher-Hoehne, PB Rupert, DD An, MC Illy, ... Nature Chemistry 9 (9), 843-849, 2017 | 81 | 2017 |
| Siderocalin-mediated recognition, sensitization, and cellular uptake of actinides BE Allred, PB Rupert, SS Gauny, DD An, CY Ralston, ... Proceedings of the National Academy of Sciences 112 (33), 10342-10347, 2015 | 73 | 2015 |
| Evaluating the potential of chelation therapy to prevent and treat gadolinium deposition from MRI contrast agents JA Rees, GJP Deblonde, DD An, C Ansoborlo, SS Gauny, RJ Abergel Scientific reports 8 (1), 4419, 2018 | 59 | 2018 |
| Actinide chelation: biodistribution and in vivo complex stability of the targeted metal ions B Kullgren, EE Jarvis, DD An, RJ Abergel Toxicology Mechanisms and Methods 23 (1), 18-26, 2013 | 47 | 2013 |
| Engineered recognition of tetravalent zirconium and thorium by chelator–protein systems: Toward flexible radiotherapy and imaging platforms I Captain, GJP Deblonde, PB Rupert, DD An, MC Illy, E Rostan, ... Inorganic chemistry 55 (22), 11930-11936, 2016 | 44 | 2016 |
| Dose-dependent efficacy and safety toxicology of hydroxypyridinonate actinide decorporation agents in rodents: towards a safe and effective human dosing regimen DI Bunin, PY Chang, RS Doppalapudi, ES Riccio, D An, EE Jarvis, ... Radiation research 179 (2), 171-182, 2013 | 43 | 2013 |
| Developing the 134Ce and 134La pair as companion positron emission tomography diagnostic isotopes for 225Ac and 227Th radiotherapeutics TA Bailey, V Mocko, KM Shield, DD An, AC Akin, ER Birnbaum, M Brugh, ... Nature Chemistry 13 (3), 284-289, 2021 | 41 | 2021 |
| Engineering mesoporous silica nanoparticles for targeted alpha therapy against breast cancer RM Pallares, P Agbo, X Liu, DD An, SS Gauny, SE Zeltmann, AM Minor, ... ACS Applied Materials & Interfaces 12 (36), 40078-40084, 2020 | 38 | 2020 |
| Highly luminescent and stable hydroxypyridinonate complexes: a step towards new curium decontamination strategies M Sturzbecher‐Hoehne, B Kullgren, EE Jarvis, DD An, RJ Abergel Chemistry–A European Journal 20 (32), 9962-9968, 2014 | 37 | 2014 |
| From early prophylaxis to delayed treatment: Establishing the plutonium decorporation activity window of hydroxypyridinonate chelating agents DD An, B Kullgren, EE Jarvis, RJ Abergel Chemico-biological interactions 267, 80-88, 2017 | 33 | 2017 |
| Genome-wide toxicogenomic study of the lanthanides sheds light on the selective toxicity mechanisms associated with critical materials RM Pallares, D Faulkner, DD An, S Hébert, A Loguinov, M Proctor, ... Proceedings of the National Academy of Sciences 118 (18), e2025952118, 2021 | 29 | 2021 |
| Developing scandium and yttrium coordination chemistry to advance theranostic radiopharmaceuticals KP Carter, GJP Deblonde, TD Lohrey, TA Bailey, DD An, KM Shield, ... Communications chemistry 3 (1), 61, 2020 | 29 | 2020 |
| Toxic heavy metal–Pb, Cd, Sn–complexation by the octadentate hydroxypyridinonate ligand archetype 3, 4, 3-LI (1, 2-HOPO) GJP Deblonde, TD Lohrey, DD An, RJ Abergel New Journal of Chemistry 42 (10), 7649-7658, 2018 | 27 | 2018 |
| Rapid detection of gadolinium-based contrast agents in urine with a chelated europium luminescent probe RM Pallares, DD An, P Tewari, ET Wang, RJ Abergel ACS sensors 5 (5), 1281-1286, 2020 | 23 | 2020 |
| Evaluating 225Ac and 177Lu Radioimmunoconjugates against Antibody–Drug Conjugates for Small-Cell Lung Cancer AL Lakes, DD An, SS Gauny, C Ansoborlo, BH Liang, JA Rees, ... Molecular pharmaceutics 17 (11), 4270-4279, 2020 | 22 | 2020 |
| 238Pu elimination profiles after delayed treatment with 3,4,3LI(1,2HOPO) in female and male Swiss-Webster mice DD An, JA Villalobos, JA Morales-Rivera, CJ Rosen, KA Bjornstad, ... International Journal of Radiation Biology 90 (11), 1055-1061, 2014 | 21 | 2014 |
| Biodistribution of the Multidentate Hydroxypyridinonate Ligand [14C]‐3,4,3‐LI(1,2‐HOPO), a Potent Actinide Decorporation Agent TA Choi, AN Endsley, DI Bunin, C Colas, DD An, JA Morales‐Rivera, ... Drug development research 76 (3), 107-122, 2015 | 20 | 2015 |
| Significance of single variables in defining adequate animal models to assess the efficacy of new radionuclide decorporation agents: using the contamination dose as an example EE Jarvis, DD An, B Kullgren, RJ Abergel Drug Development Research 73 (5), 281-289, 2012 | 18 | 2012 |
| Efficient discrimination of transplutonium actinides by in vivo models RM Pallares, DD An, GJP Deblonde, B Kullgren, SS Gauny, EE Jarvis, ... Chemical science 12 (14), 5295-5301, 2021 | 12 | 2021 |
